All times shown are PDT (GMT-7) (San Francisco)

Displaying One Session

COVID-19 Conference On-demand Channel

Oral abstract session

Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics

Moderators
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Introduction

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Characteristics and predictors of death among hospitalized patients with COVID-19 in Spain

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Risk and predictive factors of prolonged viral shedding in respiratory specimens in patients with COVID-19 admitted in an Italian reference hospital

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Sofosbuvir and daclatasvir as a potential candidate for moderate or severe COVID-19 treatment, results from a randomised controlled trial

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with severe COVID-19 treated with remdesivir

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Covid-19 convalescent plasma donors demonstrate a wide range of antibody titers to highly specific anti-SARS-CoV-2 neutralization and receptor binding domain assays

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel
Oral abstract session

Conclusion

Speaker
Session Name
Track B: Clinical science, testing (RT-PCR and serologic) and diagnoses, natural history, clinical care, ARDS care, therapeutics
Room
COVID-19 Conference On-demand Channel